Trial Profile
A Single Arm, Pilot Study to Evaluate the Efficacy and Safety of Alemtuzumab Induction and Sirolimus Maintenance in Patients With Renal Transplantion
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2015
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary) ; Methylprednisolone (Primary) ; Mycophenolate mofetil (Primary) ; Sirolimus (Primary) ; Tacrolimus (Primary) ; Azathioprine; Basiliximab; Prednisolone
- Indications Renal transplant rejection
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 26 Dec 2015 New trial record